Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of DR. LAL PATHLABS. For more details, see the DR. LAL PATHLABS quarterly results and DR. LAL PATHLABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -3.6 |
No. of shares | m | 83.48 |
1 Week | % | -2.2 |
1 Month | % | 11.4 |
1 Year | % | 18.6 |
52 week H/L | Rs | 2,766.9/1,874.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DR. LAL PATHLABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,120 | 1,846 | 2,735 | 4,243 | 2,870 | |
Low | Rs | 800 | 950 | 1,305 | 2,266 | 1,763 | |
Sales per share (Unadj.) | Rs | 144.4 | 159.6 | 189.7 | 250.5 | 241.9 | |
Earnings per share (Unadj.) | Rs | 24.1 | 27.3 | 35.6 | 42.0 | 28.9 | |
Diluted earnings per share | Rs | 24.0 | 27.3 | 35.5 | 42.0 | 28.9 | |
Cash flow per share (Unadj.) | Rs | 28.6 | 36.0 | 44.8 | 55.0 | 46.9 | |
Dividends per share (Unadj.) | Rs | 6.00 | 12.00 | 20.00 | 12.00 | 12.00 | |
Adj. dividends per share | Rs | 5.99 | 11.98 | 19.97 | 11.98 | 11.98 | |
Avg Dividend yield | % | 0.6 | 0.9 | 1.0 | 0.4 | 0.5 | |
Book value per share (Unadj.) | Rs | 110.1 | 120.0 | 144.6 | 173.2 | 192.9 | |
Adj. book value per share | Rs | 109.9 | 119.8 | 144.4 | 172.9 | 192.6 | |
Shares outstanding (eoy) | m | 83.34 | 83.34 | 83.34 | 83.34 | 83.37 | |
Price / Sales ratio | x | 6.6 | 8.8 | 10.6 | 13.0 | 9.6 | |
Avg P/E ratio | x | 39.9 | 51.2 | 56.8 | 77.4 | 80.1 | |
P/CF ratio (eoy) | x | 33.5 | 38.8 | 45.1 | 59.2 | 49.4 | |
Price / Book Value ratio | x | 8.7 | 11.7 | 14.0 | 18.8 | 12.0 | |
Dividend payout | % | 24.9 | 43.9 | 56.2 | 28.6 | 41.5 | |
Avg Mkt Cap | Rs m | 80,008 | 116,512 | 168,365 | 271,229 | 193,109 | |
Total wages/salary | Rs m | 2,083 | 2,426 | 2,737 | 3,649 | 3,765 |
DR. LAL PATHLABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 12,034 | 13,304 | 15,813 | 20,874 | 20,169 | |
Other income | Rs m | 459 | 550 | 513 | 525 | 417 | |
Total revenues | Rs m | 12,494 | 13,854 | 16,326 | 21,400 | 20,586 | |
Gross profit | Rs m | 2,937 | 3,436 | 4,363 | 5,607 | 4,898 | |
Depreciation | Rs m | 382 | 728 | 772 | 1,081 | 1,502 | |
Interest | Rs m | 8 | 153 | 160 | 302 | 375 | |
Profit before tax | Rs m | 3,005 | 3,105 | 3,944 | 4,750 | 3,438 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,001 | 829 | 979 | 1,247 | 1,028 | |
Profit after tax | Rs m | 2,005 | 2,276 | 2,965 | 3,503 | 2,411 | |
Gross profit margin | % | 24.4 | 25.8 | 27.6 | 26.9 | 24.3 | |
Effective tax rate | % | 33.3 | 26.7 | 24.8 | 26.3 | 29.9 | |
Net profit margin | % | 16.7 | 17.1 | 18.7 | 16.8 | 12.0 |
DR. LAL PATHLABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 8,136 | 8,926 | 11,452 | 8,752 | 9,731 | |
Current liabilities | Rs m | 1,383 | 2,273 | 2,743 | 5,000 | 4,698 | |
Net working cap to sales | % | 56.1 | 50.0 | 55.1 | 18.0 | 25.0 | |
Current ratio | x | 5.9 | 3.9 | 4.2 | 1.8 | 2.1 | |
Inventory Days | Days | 69 | 55 | 21 | 20 | 38 | |
Debtors Days | Days | 16 | 14 | 15 | 15 | 13 | |
Net fixed assets | Rs m | 2,554 | 4,588 | 4,881 | 14,346 | 13,721 | |
Share capital | Rs m | 833 | 833 | 833 | 833 | 834 | |
"Free" reserves | Rs m | 8,341 | 9,166 | 11,219 | 13,600 | 15,247 | |
Net worth | Rs m | 9,175 | 9,999 | 12,053 | 14,433 | 16,080 | |
Long term debt | Rs m | 0 | 0 | 1 | 1,668 | 833 | |
Total assets | Rs m | 10,690 | 13,515 | 16,333 | 23,097 | 23,451 | |
Interest coverage | x | 359.2 | 21.3 | 25.6 | 16.7 | 10.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0.1 | 0.1 | |
Sales to assets ratio | x | 1.1 | 1.0 | 1.0 | 0.9 | 0.9 | |
Return on assets | % | 18.8 | 18.0 | 19.1 | 16.5 | 11.9 | |
Return on equity | % | 21.9 | 22.8 | 24.6 | 24.3 | 15.0 | |
Return on capital | % | 32.9 | 32.6 | 34.0 | 31.4 | 22.5 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0.7 | 0.6 | 0.7 | 0.5 | 0.5 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 88 | 86 | 105 | 98 | 101 | |
Fx inflow | Rs m | 155 | 177 | 143 | 188 | 220 | |
Fx outflow | Rs m | 88 | 86 | 105 | 98 | 101 | |
Net fx | Rs m | 67 | 91 | 38 | 90 | 119 |
DR. LAL PATHLABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,185 | 2,839 | 3,982 | 4,467 | 4,560 | |
From Investments | Rs m | -997 | -261 | -2,120 | -4,492 | -2,873 | |
From Financial Activity | Rs m | -553 | -1,904 | -1,386 | 1,365 | -2,832 | |
Net Cashflow | Rs m | 635 | 673 | 476 | 1,339 | -1,145 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Arvind Lal | COMP SEC: Rajat Kalra | YEAR OF INC: 1995 | BSE CODE: 539524 | FV (Rs): 10 | DIV YIELD (%): 0.5 |
Read: DR. LAL PATHLABS 2022-23 Annual Report Analysis
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare DR. LAL PATHLABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets yesterday.